Literature DB >> 3167610

Menstrual factors and risk of breast cancer.

L A Brinton1, C Schairer, R N Hoover, J F Fraumeni.   

Abstract

A case control study of 2,908 breast cancer cases and 3,180 controls, derived from a nationwide screening program, enabled evaluation of the relationship of breast cancer risk to a variety of menstrual factors. Risk was significantly inversely related to age at menarche, with women who first menstruated at age 15 or later having a 23% lower risk than those with menarche prior to the age of 12. There was a higher relative risk (1.3) for premenopausal than menopausal women. In contrast to previous studies, there was only a slight increase in risk associated with a late age at natural menopause, possibly owing to errors in recall. Bilateral oophorectomy at an early age exerted a protective influence on breast cancer risk, with effects manifested approximately 10 to 15 years after oophorectomy. Women who had both ovaries removed prior to the age of 40 had a 45% reduced risk compared to women with a natural menopause at ages 50 to 54. In addition, bilateral oophorectomy at an early age was associated with a lowered risk relative to natural menopause at a comparable age, which may reflect the more pronounced and sudden decline in endogenous hormones associated with the surgery. Although these results were based on patient reports regarding the types of surgical menopause experienced, validation against medical records showed close correspondence regarding the number of ovaries removed.

Entities:  

Mesh:

Year:  1988        PMID: 3167610     DOI: 10.3109/07357908809080645

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  38 in total

1.  Evolution of age at menarche and at onset of regular cycling in a large cohort of French women.

Authors:  F Clavel-Chapelon
Journal:  Hum Reprod       Date:  2002-01       Impact factor: 6.918

2.  Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women.

Authors:  F Clavel-Chapelon
Journal:  Cancer Causes Control       Date:  2002-11       Impact factor: 2.506

3.  Diet and age at menarche.

Authors:  J Moisan; F Meyer; S Gingras
Journal:  Cancer Causes Control       Date:  1990-09       Impact factor: 2.506

4.  Altered carcinogenesis and proteome in mammary glands of rats after prepubertal exposures to the hormonally active chemicals bisphenol a and genistein.

Authors:  Angela M Betancourt; Jun Wang; Sarah Jenkins; Jim Mobley; Jose Russo; Coral A Lamartiniere
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

5.  Hormone therapy and young-onset breast cancer.

Authors:  Katie M O'Brien; Chunyuan Fei; Dale P Sandler; Hazel B Nichols; Lisa A DeRoo; Clarice R Weinberg
Journal:  Am J Epidemiol       Date:  2015-02-18       Impact factor: 4.897

6.  Breast Cancer Risk - Genes, Environment and Clinics.

Authors:  P A Fasching; A B Ekici; B R Adamietz; D L Wachter; A Hein; C M Bayer; L Häberle; C R Loehberg; S M Jud; K Heusinger; M Rübner; C Rauh; M R Bani; M P Lux; R Schulz-Wendtland; A Hartmann; M W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2011-12       Impact factor: 2.915

Review 7.  Rating the risk factors for breast cancer.

Authors:  S Eva Singletary
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

Review 8.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

9.  Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study.

Authors:  Louise A Brinton; Llewellyn Smith; Gretchen L Gierach; Ruth M Pfeiffer; Sarah J Nyante; Mark E Sherman; Yikyung Park; Albert R Hollenbeck; Cher M Dallal
Journal:  Cancer Causes Control       Date:  2014-05-09       Impact factor: 2.506

10.  Association of bilateral oophorectomy and body fatness in a representative sample of US women.

Authors:  Anne Marie McCarthy; Andy Menke; Kala Visvanathan
Journal:  Gynecol Oncol       Date:  2013-02-18       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.